Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Anti-Interleukin-6 (IL-6) antibodies & Crohn’s disease

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Anti-Interleukin-6 (IL-6) antibodies show promise in Crohn's disease. However, it is not a standard treatment. Safety concerns limited its development. It is not approved based on trial records.
Ito 2003 Curr Pharm Des 9(4): 295-305
Ito 2005 J Gastroenterol 40(Suppl_16): 32-4

…

References (Sources)

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease
Ito et al. 2004 Gastroenterology 126: 989-96
Anti-interleukin-6 therapy for Crohn's disease
Ito 2003 Curr Pharm Des 9(4): 295-305
Review
Treatment of Crohn's disease with anti-IL-6 receptor antibody
Ito 2005 J Gastroenterol 40(Suppl_16): 32-4

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Anti-Interleukin-6 (IL-6) antibodies & Crohn’s disease

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat